JP2025090679A5 - - Google Patents
Info
- Publication number
- JP2025090679A5 JP2025090679A5 JP2025036066A JP2025036066A JP2025090679A5 JP 2025090679 A5 JP2025090679 A5 JP 2025090679A5 JP 2025036066 A JP2025036066 A JP 2025036066A JP 2025036066 A JP2025036066 A JP 2025036066A JP 2025090679 A5 JP2025090679 A5 JP 2025090679A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- amino acid
- antibody
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962800869P | 2019-02-04 | 2019-02-04 | |
| US62/800,869 | 2019-02-04 | ||
| JP2021545713A JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
| PCT/US2020/016606 WO2020163353A1 (en) | 2019-02-04 | 2020-02-04 | Connexin 43 antibodies and use thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545713A Division JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025090679A JP2025090679A (ja) | 2025-06-17 |
| JP2025090679A5 true JP2025090679A5 (https=) | 2025-08-21 |
Family
ID=71947290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545713A Active JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
| JP2025036066A Pending JP2025090679A (ja) | 2019-02-04 | 2025-03-07 | コネキシン４３抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545713A Active JP7709917B2 (ja) | 2019-02-04 | 2020-02-04 | コネキシン４３抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12187794B2 (https=) |
| EP (1) | EP3920969A4 (https=) |
| JP (2) | JP7709917B2 (https=) |
| KR (1) | KR20210153039A (https=) |
| CN (2) | CN119700967A (https=) |
| AU (3) | AU2020219112A1 (https=) |
| CA (1) | CA3128987A1 (https=) |
| IL (2) | IL285369B2 (https=) |
| WO (1) | WO2020163353A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12227561B2 (en) | 2018-04-02 | 2025-02-18 | Alamab Therapeutics, Inc. | Connexin 43 antibodies and use thereof |
| JP2023537316A (ja) * | 2020-07-31 | 2023-08-31 | アラマブ セラピューティクス， インコーポレイテッド | 抗コネキシン抗体製剤 |
| US20250002569A1 (en) * | 2023-06-30 | 2025-01-02 | Alamab Therapeutics, Inc. | Method of treating osteoarthritis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
| US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
| EP3960855A1 (en) | 2001-12-28 | 2022-03-02 | Chugai Seiyaku Kabushiki Kaisha | Method for stabilizing proteins |
| US6745478B2 (en) | 2002-07-18 | 2004-06-08 | Delillo Dominick D. | Multi-purpose work knife |
| KR101225299B1 (ko) | 2003-12-10 | 2013-01-24 | 메다렉스, 인코포레이티드 | 인터페론 알파 항체 및 그의 용도 |
| DK1959981T3 (da) | 2005-02-03 | 2020-01-27 | Coda Therapeutics Ltd | Anti-connexin 43 forbindelser til behandling af kroniske sår |
| MX2010012324A (es) | 2008-05-15 | 2011-01-14 | Biogen Idec Inc | Anticuerpos anti-fn14 y usos de los mismos. |
| US20110223204A1 (en) | 2008-06-04 | 2011-09-15 | Bradford J Duft | Treatment of pain with gap junction modulation compounds |
| CN103429732B (zh) | 2010-12-27 | 2015-09-16 | Lsip基金运营联合公司 | iPS细胞及其制造方法 |
| CA2921652A1 (en) * | 2013-08-21 | 2015-02-26 | Manuel A. Riquelme | Compositions and methods for targeting connexin hemichannels |
| US9493552B2 (en) | 2013-11-15 | 2016-11-15 | China Synthetic Rubber Corporation | Therapeutic biologic for treatment of hepatocellular carcinoma |
| US10465188B2 (en) | 2014-08-22 | 2019-11-05 | Auckland Uniservices Limited | Channel modulators |
| WO2017024465A1 (en) * | 2015-08-10 | 2017-02-16 | Innovent Biologics (Suzhou) Co., Ltd. | Pd-1 antibodies |
| EP3419998A4 (en) * | 2016-02-26 | 2019-09-25 | The Board of Regents of The University of Texas System | CONNEXIN (CX) 43 HEMICANAL BINDING ANTIBODIES AND USES THEREOF |
| US12227561B2 (en) | 2018-04-02 | 2025-02-18 | Alamab Therapeutics, Inc. | Connexin 43 antibodies and use thereof |
| JP2023537316A (ja) * | 2020-07-31 | 2023-08-31 | アラマブ セラピューティクス， インコーポレイテッド | 抗コネキシン抗体製剤 |
-
2020
- 2020-02-04 IL IL285369A patent/IL285369B2/en unknown
- 2020-02-04 KR KR1020217027864A patent/KR20210153039A/ko active Pending
- 2020-02-04 CN CN202411949862.9A patent/CN119700967A/zh active Pending
- 2020-02-04 IL IL320816A patent/IL320816A/en unknown
- 2020-02-04 US US17/767,171 patent/US12187794B2/en active Active
- 2020-02-04 AU AU2020219112A patent/AU2020219112A1/en not_active Abandoned
- 2020-02-04 JP JP2021545713A patent/JP7709917B2/ja active Active
- 2020-02-04 CA CA3128987A patent/CA3128987A1/en active Pending
- 2020-02-04 WO PCT/US2020/016606 patent/WO2020163353A1/en not_active Ceased
- 2020-02-04 CN CN202080002561.9A patent/CN112384244B/zh active Active
- 2020-02-04 EP EP20752507.2A patent/EP3920969A4/en active Pending
-
2022
- 2022-08-18 AU AU2022218583A patent/AU2022218583B9/en active Active
-
2024
- 2024-11-21 US US18/955,222 patent/US20250230233A1/en active Pending
-
2025
- 2025-03-07 JP JP2025036066A patent/JP2025090679A/ja active Pending
-
2026
- 2026-02-20 AU AU2026201299A patent/AU2026201299A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025090679A5 (https=) | ||
| JP2025065427A5 (https=) | ||
| JP2023538891A5 (https=) | ||
| JP2024109678A5 (https=) | ||
| CA2466629A1 (en) | Expression control using variable intergenic sequences | |
| JP2023121798A5 (https=) | ||
| JP2023093753A5 (https=) | ||
| TW201815825A (zh) | 經修飾之抗原結合fab片段及包含其之抗原結合分子 | |
| JP2025508827A5 (https=) | ||
| JP2023058590A5 (https=) | ||
| JP2004041195A5 (https=) | ||
| CN115461368A (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| JP2020505017A5 (https=) | ||
| JP2020505919A5 (https=) | ||
| JP2007530435A5 (https=) | ||
| JP2024056817A5 (https=) | ||
| JP2022534135A5 (https=) | ||
| JP2003527078A5 (https=) | ||
| CN113354729A (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2004502409A5 (https=) | ||
| JP2002503495A5 (https=) | ||
| JP2020505927A5 (https=) | ||
| JP2025067915A5 (https=) | ||
| JP2004528803A5 (https=) | ||
| JP2023530663A5 (https=) |